2 hours Guggenheim Begins Coverage on Adicet Bio (NASDAQ:ACET) MarketBeat
Guggenheim began coverage on shares of Adicet Bio in a research report on Monday. They issued a “buy” rating and a $7.00 price target for the company.
Guggenheim began coverage on shares of Adicet Bio in a research report on Monday. They issued a “buy” rating and a $7.00 price target for the company.